{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:38:12Z","timestamp":1789771092418,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005689","name":"G\u00f6teborgs L\u00e4kares\u00e4llskap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.maturitas.2005.07.008","type":"journal-article","created":{"date-parts":[[2005,9,28]],"date-time":"2005-09-28T07:08:36Z","timestamp":1127891316000},"page":"430-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The effect of continuous combined HRT on glucose homeostasis and plasma lipids"],"prefix":"10.1016","volume":"53","author":[{"given":"Louise","family":"Thunell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Glassell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-\u00c5ke","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.maturitas.2005.07.008_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/oxfordjournals.aje.a113654","article-title":"Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study","volume":"118","author":"Barrett-Connor","year":"1983","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.maturitas.2005.07.008_bib2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","article-title":"Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses\u2019 health study","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.maturitas.2005.07.008_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1471-0528.1992.tb14414.x","article-title":"The risk of acute myocardial infarction after oestrogen and oestrogen\u2013progestogen replacement","volume":"99","author":"Falkeborn","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.maturitas.2005.07.008_bib4","doi-asserted-by":"crossref","unstructured":"Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94(6):646\u201350.","DOI":"10.1016\/0002-9343(93)90218-E"},{"issue":"3","key":"10.1016\/j.maturitas.2005.07.008_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.maturitas.2005.07.008_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.maturitas.2005.07.008_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/clinchem\/32.1.146","article-title":"Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women","volume":"32","author":"Lapidus","year":"1986","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.maturitas.2005.07.008_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2337\/diab.40.1.123","article-title":"Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden","volume":"40","author":"Lindstedt","year":"1991","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.maturitas.2005.07.008_bib9","first-page":"56","article-title":"Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men","volume":"77","author":"Haffner","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.maturitas.2005.07.008_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/diacare.17.5.405","article-title":"Testosterone concentrations in women and men with NIDDM","volume":"17","author":"Andersson","year":"1994","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.maturitas.2005.07.008_bib11","first-page":"638","article-title":"Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus","volume":"82","author":"Andersson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.maturitas.2005.07.008_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001721-199903000-00004","article-title":"The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus","volume":"10","author":"Hahn","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"7","key":"10.1016\/j.maturitas.2005.07.008_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s001250050758","article-title":"Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM","volume":"40","author":"Brussaard","year":"1997","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.maturitas.2005.07.008_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/01.ATV.17.2.324","article-title":"Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus","volume":"17","author":"Brussaard","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.maturitas.2005.07.008_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.maturitas.2005.07.008_bib16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1471-0528.2000.tb10406.x","article-title":"Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension","volume":"107","author":"Szekacs","year":"2000","journal-title":"Bjog"},{"issue":"4","key":"10.1016\/j.maturitas.2005.07.008_bib17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1464-5491.2000.00281.x","article-title":"Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate","volume":"17","author":"Owens","year":"2000","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.maturitas.2005.07.008_bib18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1365-2265.2003.01906.x","article-title":"Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?","volume":"59","author":"McKenzie","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.maturitas.2005.07.008_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/009127009803801204","article-title":"Lipid and lipoprotein responses to oral combined hormone replacement therapy in normolipemic obese women with controlled type 2 diabetes mellitus","volume":"38","author":"Lilley","year":"1998","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.maturitas.2005.07.008_bib20","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2337\/diacare.22.9.1401","article-title":"Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study","volume":"22","author":"Samaras","year":"1999","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.maturitas.2005.07.008_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-5122(99)00112-7","article-title":"The effects of hormone replacement therapy on plasma lipids in type II diabetes","volume":"34","author":"Manwaring","year":"2000","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.maturitas.2005.07.008_bib22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1034\/j.1600-0412.1999.780316.x","article-title":"The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM","volume":"78","author":"Andersson","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"10.1016\/j.maturitas.2005.07.008_bib23","first-page":"1111","article-title":"Effects of deprivation and replacement by percutaneous 17 beta estradiol and oral progesterone on blood pressure and metabolic parameters in menopause patients with non-insulin-dependent diabetes","volume":"84","author":"Mosnier-Pudar","year":"1991","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.maturitas.2005.07.008_bib24","unstructured":"World Health Organisation, Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus, Geneva: World Health Organisation, 1999."},{"key":"10.1016\/j.maturitas.2005.07.008_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/05678067209176152","article-title":"A new whole body monitoring laboratory","volume":"313","author":"Skoldborn","year":"1972","journal-title":"Acta Radiol Suppl"},{"key":"10.1016\/j.maturitas.2005.07.008_bib26","doi-asserted-by":"crossref","unstructured":"Forbes GB, Gallup J, Hursh JB. Science, vol. 133, 1961: estimation of total body fat from potassium-40 content. Nutr Rev 1991;49(4):109\u201311.","DOI":"10.1111\/j.1753-4887.1991.tb02998.x"},{"issue":"3","key":"10.1016\/j.maturitas.2005.07.008_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0026-0495(92)90271-B","article-title":"Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women","volume":"41","author":"Haffner","year":"1992","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.maturitas.2005.07.008_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJM198909073211004","article-title":"Menopause and risk factors for coronary heart disease","volume":"321","author":"Matthews","year":"1989","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.maturitas.2005.07.008_bib29","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/archinte.161.14.1772","article-title":"The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes: a randomized controlled trial","volume":"161","author":"Manning","year":"2001","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.maturitas.2005.07.008_bib30","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI114625","article-title":"Lipoprotein (a). Heterogeneity and biological relevance","volume":"85","author":"Scanu","year":"1990","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.maturitas.2005.07.008_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0038-1646598","article-title":"Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients\u2014relationship with plasma insulin","volume":"61","author":"Juhan-Vague","year":"1989","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.maturitas.2005.07.008_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/13697130310001651508","article-title":"Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1","volume":"7","author":"Borgfeldt","year":"2004","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.maturitas.2005.07.008_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/1047-2797(92)90011-E","article-title":"A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus","volume":"2","author":"Manson","year":"1992","journal-title":"Ann Epidemiol"},{"issue":"7","key":"10.1016\/j.maturitas.2005.07.008_bib34","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.maturitas.2005.07.008_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.maturitas.2005.07.008_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1463-1326.2004.00294.x","article-title":"Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes","volume":"6","author":"Scott","year":"2004","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.maturitas.2005.07.008_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1471-0528.1997.tb11457.x","article-title":"Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up","volume":"104","author":"Crook","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.maturitas.2005.07.008_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/000331970305400402","article-title":"The effects of transdermal estradiol alone or with cyclical dydrogesterone on markers of cardiovascular disease risk in postmenopausal women with type 2 diabetes: a pilot study","volume":"54","author":"Stojanovic","year":"2003","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.maturitas.2005.07.008_bib39","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(01)01699-5","article-title":"Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974 to 2000","volume":"75","author":"Godsland","year":"2001","journal-title":"Fertil Steril"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2005.07.008_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.maturitas.2003.09.015","article-title":"Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection","volume":"46","author":"Rosano","year":"2003","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.maturitas.2005.07.008_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-5122(02)00069-5","article-title":"Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion and elimination in hysterectomised women","volume":"42","author":"Manassiev","year":"2002","journal-title":"Maturitas"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:41:24Z","timestamp":1759912884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512205001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0378512205001921"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.07.008","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of continuous combined HRT on glucose homeostasis and plasma lipids","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2005.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}